EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Mesenchymal Stem Cell Therapy in Traumatic Spinal Cord Injury: A Systematic Review

Rodrigo Montoto-Meijide iD, Rosa Meijide-Faílde, Silvia María Díaz-Prado iD, Antonio Montoto-Marqués iD

International Journal of Molecular Sciences · 20.07.2023 · 24 (14) · 11719

DOI: 10.3390/ijms241411719 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.07.2023. Verfasst von Rodrigo Montoto-Meijide und 3 weiteren Autor:innen. Beteiligte Einrichtung: Complejo Hospitalario Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain. Hauptthemen laut MEDLINE: Mesenchymal Stem Cell Transplantation, Spinal Cord Injuries, Mesenchymal Stem Cells. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recovery from a traumatic spinal cord injury (TSCI) is challenging due to the limited regenerative capacity of the central nervous system to restore cells, myelin, and neural connections. Cell therapy, particularly with mesenchymal stem cells (MSCs), holds significant promise for TSCI treatment. This systematic review aims to analyze the efficacy, safety, and therapeutic potential of MSC-based cell therapies in TSCI. A comprehensive search of PUBMED and COCHRANE databases until February 2023 was conducted, combining terms such as “spinal cord injury,” “stem cells,” “stem cell therapy,” “mesenchymal stem cells,” and “traumatic spinal cord injury”. Among the 53 studies initially identified, 22 (21 clinical trials and 1 case series) were included. Findings from these studies consistently demonstrate improvements in AIS (ASIA Impairment Scale) grades, sensory scores, and, to a lesser extent, motor scores. Meta-analyses further support these positive outcomes. MSC-based therapies have shown short- and medium-term safety, as indicated by the absence of significant adverse events within the studied timeframe. However, caution is required when drawing generalized recommendations due to the limited scientific evidence available. Further research is needed to elucidate the long-term safety and clinical implications of these advancements. Although significant progress has been made, particularly with MSC-based therapies, additional studies exploring other potential future therapies such as gene therapies, neurostimulation techniques, and tissue engineering approaches are essential for a comprehensive understanding of the evolving TSCI treatment landscape.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem Cell TransplantationSpinal Cord InjuriesMesenchymal Stem CellsHumansCell- and Tissue-Based TherapyMyelin SheathSpinal Cord

Stichwörter der Autor:innen

cell therapymesenchymal stem cellstraumatic spinal cord injury

Autor:innen und Institutionen

  • Complejo Hospitalario Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain.
  • Grupo de Investigación en Terapia Celular y Medicina Regenerativa, Instituto de Investigación Biomédica de A Coruña (INIBIC), Centro Interdisciplinar de Química y Biología (CICA), Universidade da Coruña, 15071 A Coruña,…
  • Departamento de Fisioterapia, Medicina y Ciencias Biomédicas, Universidade da Coruña, 15071 A Coruña, Spain.
  • Unidad de Lesionados Medulares, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña, 15006 A Coruña, Spain.

ORCID-Profile: Rodrigo Montoto-Meijide, Silvia María Díaz-Prado, Antonio Montoto-Marqués

Förderung

  • Instituto de Salud Carlos III
  • European Union

Zitieren

APA

Montoto-Meijide, R., Meijide-Faílde, R., Díaz-Prado, S. M., & Montoto-Marqués, A. (2023). Mesenchymal Stem Cell Therapy in Traumatic Spinal Cord Injury: A Systematic Review. International Journal of Molecular Sciences, 24(14), 11719. https://doi.org/10.3390/ijms241411719

Vancouver

Montoto-Meijide R, Meijide-Faílde R, Díaz-Prado SM, Montoto-Marqués A. Mesenchymal Stem Cell Therapy in Traumatic Spinal Cord Injury: A Systematic Review. International Journal of Molecular Sciences. 2023;24(14):11719. doi:10.3390/ijms241411719

BibTeX
@article{MontotoMeijide2023,
  author = {Montoto-Meijide, Rodrigo and Meijide-Faílde, Rosa and Díaz-Prado, Silvia María and Montoto-Marqués, Antonio},
  title = {Mesenchymal Stem Cell Therapy in Traumatic Spinal Cord Injury: A Systematic Review},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {14},
  pages = {11719},
  doi = {10.3390/ijms241411719}
}
Kostenlos starten →